AVXL

Anavex Life Sciences Corp.

Price

$3.39

return (12m)

-64.09%

p/e

-8.72

p/bv

2.44

DIVIDEND YIELD

0.00%

AVXL price

Anavex Life Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AVXL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

32.68%

3 months

25.09%

1 year

-64.09%

2 years

-46.02%

5 years

-82.81%

10 years

5.61%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AVXL

Valuation

P/E

-8.72

Sector -4.38

Industry -4.38

P/BV

2.44

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-26.27

Sector -263.09

Industry -263.09

EV/EBIT

-26.27

Sector -702.90

Industry -702.90

P/EBITDA

-8.73

Sector -4.39

Industry -4.39

P/EBIT

-8.73

Sector -4.73

Industry -4.73

P/Total Assets

2.31

Sector 1.49

Industry 1.49

P/Net Current Assets

2.44

Sector -11.70

Industry -11.70

P/Working Capital

2.44

Sector -3.19

Industry -3.19

EPS

-0.37

Sector -2.14

Industry -2.14

BVPS

1.31

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-28.01%

Sector -65.14%

Industry -65.14%

ROA

-26.47%

Sector -65.53%

Industry -65.53%

ROIC

-1,820.16%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

18.24

Sector 2.90

Industry 2.90

Net Debt / EBITDA

19.72

Sector -6.07

Industry -6.07

Net Debt / EBIT

19.72

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.05

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.95

Sector 0.41

Industry 0.41

Liabilities/Assets

0.05

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-3.59%

Sector -

Industry -

Fundamentals AVXL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AVXL Anavex Life Sciences Corp.	$3.39	-64.65%	0.00%	-8.72	2.44	-28.01%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AVXL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Anavex Life Sciences

Anavex Life Sciences Corp.

Average Investor10 user rating

4.0 (1 people)

United States

22 years

Founded: 2004

2006

Time since IPO - 20 years

25

Employees

Anavex Life Sciences Corp. (United States) is listed on the Nasdaq and has a market capitalization of $297.14 million, with shareholders equity totaling $121.71 million.

The company employs approximately 25 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Anavex Life Sciences Corp. reported $- in revenue, generating net income of $-34.09 million.

Key financial metrics include a P/E ratio of -8.72, a price-to-book (P/B) ratio of 2.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AVXL.

Market cap

$297.14 million

Net worth

$121.71 million

$121,710,000.00

Assets

$128.77 million

$128,770,000.00

Total Shares Outstanding

93.00 million

93,000,000

Average Daily Trading Volume

$1.20 million

$1,199,618.00

Sector

Health Care

Industry

Biotechnology

AVXL

AVXL revenue and profits

Financial Results AVXL

DRAG THE FRAME TO SEE MORE DATA

AVXL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Anavex Life Sciences (AVXL) today?

A cotação de Anavex Life Sciences (AVXL) hoje está em US$ 3.39, com uma variação de -64.09% em relação ao último ano. A cotação de Anavex Life Sciences (AVXL) iniciou o ano negociando na casa dos US$ 3.56 e hoje está em US$ 3.39. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Anavex Life Sciences (AVXL) e dados de ações do Ibovespa e mercados internacionais.

Quando Anavex Life Sciences (AVXL) paga dividendos?

Anavex Life Sciences (AVXL) não distribuiu dividendos no último ano.

Is Anavex Life Sciences (AVXL) a good investment?

Atualmente, Anavex Life Sciences (AVXL) está cotada a US$ 3.39, com um P/L de -8.72, representando um desvio de -1,427% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -64.09 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -64.09%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Anavex Life Sciences (AVXL) stock?

Investir em ações de Anavex Life Sciences (AVXL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Anavex Life Sciences (AVXL) yield today?

A rentabilidade de Anavex Life Sciences (AVXL) foi de 32.68% no último mês, -64.09% no último ano e -82.81% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Anavex Life Sciences (AVXL) hoje, o investimento total seria de US$ 339.00, com base na cotação atual de US$ 3.39.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 121.73
Em 5 anos: US$ 58.27
Em 10 anos: US$ 358.02

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

AVXL

Anavex Life Sciences Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment AVXL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING AVXL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Anavex Life Sciences

Anavex Life Sciences Corp.

United States

22 years

2006

25

PROFIT X PRICE AVXL

Financial Results AVXL

AVXL cash flow

Asset, Revenue and Profit Growth - AVXL

AVXL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions